Natarajan Sethuraman - President, Research & Develop. at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Research & Develop.
Stock Symbol
TRDA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Natarajan Sethuraman - trading volume in the past year for Entrada Therapeutics, Inc.

Holdings reported by Natarajan Sethuraman for Entrada Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 145K $2.92M $20.15 Dec 3, 2024 Direct
Stock Option (Right to Buy) 66.8K Mar 1, 2024 Direct Common Stock

Transactions reported by Natarajan Sethuraman for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.